Re-Aim Therapeutics Ltd
15689618
Healthy
- Negative net worth (-10)
Details
Compliance
Last accounts
31/03/2026
small
Next accounts due
31/12/2027
Confirmation statement
Last: 28/04/2026
Due 12/05/2027
Industry
Officers
director · Since 02/10/2025
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 50
Also on 4 other boards
director · Since 02/10/2025
COMMERCIAL DIRECTOR
FRENCH · ENGLAND · Age 32
Also on 1 other board
Former
director · Resigned 02/10/2025
director · Resigned 18/02/2026
Persons with Significant Control
Dr Asher Maroof
British · United Kingdom · Age 50
35, Ballards Lane, London, N3 1XW
Notified 29/04/2024
Syncona Portfolio Limited
Frances House, Sir William Place, St Peter Port
Reg: 62778 · Guernsey Registry · Non Cellular Company
Notified 03/10/2025
Change History
Active
Private Limited Company
INNOVATION BUILDING OLD CAMPUS ROAD
OXFORD
CompanyRankvs 1412+ SIC 72110 peers54
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£0
Balance sheet strength
Cash
£5.1M
Cash in the bank
Net Current Assets
£5.3M
Working capital
Current Assets
£5.4M
Current Liabilities
£166k
Fixed Assets
£65k
Debtors
£312k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2026 | 32.67 |
Derived from filed accounts. Not audited figures.